Refine Results
  1. "American Society of Clinical Oncology"
Formats
  1. Meeting Abstract (4889)
  2. Journal Article (2315)
  3. Review (50)
  4. Editorial (42)
  5. Guidelines (28)
  6. Correspondence (27)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (5038)
  2. Solid Tumor Oncology Division (4349)
  3. Survivorship Research (1646)
  4. Genitourinary Oncology Service (1429)
  5. Surgery (1366)
  6. Population Sciences Research Program (1149)

More Groups

People
  1. Robert Motzer (382)
  2. Howard Scher (320)
  3. Leonard Saltz (268)
  4. Dean Bajorin (252)
  5. Clifford Hudis (248)
  6. Mark Kris (231)

More People

Years
  1. 2022 (142)
  2. 2021 (519)
  3. 2020 (547)
  4. 2019 (516)
  5. 2018 (604)
  6. 2017 (375)

More Years

Publications
  1. Journal of Clinical Oncology (6966)
  2. Journal of Oncology Practice (124)
  3. American Society of Clinical Oncology Educational Book (110)
  4. JCO Precision Oncology (83)
  5. JCO Oncology Practice (36)
  6. JCO Clinical Cancer Informatics (30)

More Publications

Publishers
  1. American Society of Clinical Oncology (7358)

Results (7358)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ALK inhibitors in patients with ALK fusion-positive GI cancers: An international data set and a molecular case series
    Journal Article

    Ambrosini, M.; Del Re, M.; Manca, P.; Hendifar, A.; Drilon, A.; Harada, G.; Ree, A. H.; Klempner, S.; Maelandsmo, G. M.; Flatmark, K.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Payer-imposed quantity limits for antiemetics: Everybody hurts
    Editorial

    Haque, W.; Sedhom, R.; Chino, F.; Royce, T. J.; Gupta, A.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • The hardest weeks of my life: A qualitative study of experiences, practice changes, and emotional burden of New York City oncology physicians during the COVID-19 surge in 2020
    Journal Article

    Lynch, K. A.; Green, A.; Saltz, L.; Epstein, A. S.; Romano, D. R.; Vera, J.; Nelson, J. E.
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Implementation strategies to increase clinical trial enrollment in a community-academic partnership and impact on Hispanic representation: An interrupted time series analysis
    Journal Article

    Ledesma Vicioso, N.; Lin, D.; Gomez, D. R.; Yang, J. T.; Lee, N. Y.; Rimner, A.; Yamada, Y.; Zelefsky, M. J.; Kalman, N. S.; Rutter, C. E.; more...
    JCO Oncology Practice (2022)

    Fulltext@MSK | Save
  • Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy
    Journal Article

    Di Meglio, A.; Havas, J.; Gbenou, A. S.; Martin, E.; El-Mouhebb, M.; Pistilli, B.; Menvielle, G.; Dumas, A.; Everhard, S.; Martin, A. L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Evolving role of prostate-specific membrane antigen-positron emission tomography in metastatic hormone-sensitive prostate cancer: More questions than answers?
    Editorial

    Hussain, M.; Carducci, M. A.; Clarke, N.; Fenton, S. E.; Fizazi, K.; Gillessen, S.; Jacene, H.; Morris, M. J.; Saad, F.; Sartor, O.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Considerations on integrating prostate-specific membrane antigen positron emission tomography imaging into clinical prostate cancer trials by National Clinical Trials Network Cooperative Groups
    Guidelines

    Schòˆder, H.; Hope, T. A.; Knopp, M.; Kelly, W. K.; Michalski, J. M.; Lerner, S. P.; Tawab-Amiri, A.; Mann, B. S.; Lin, D. W.; Yu, E. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • SWOG 1318: A phase II trial of blinatumomab followed by POMP maintenance in older patients with newly diagnosed philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
    Journal Article

    Advani, A. S.; Moseley, A.; O'Dwyer, K. M.; Wood, B. L.; Fang, M.; Wieduwilt, M. J.; Aldoss, I.; Park, J. H.; Klisovic, R. B.; Baer, M. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • PD-1 or PD-L1 blockade adds little to combination of BRAF and MEK inhibition in the treatment of BRAF V600-mutated melanoma
    Editorial

    Callahan, M. K.; Chapman, P. B.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Reply to M.B. Abid
    Correspondence

    Santomasso, B.; Ghosh, M.; Schneider, B.; Bollin, K.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save